Severe COVID-19-induced AKI: a 3-month follow-up

Publié en April 2021 Clinical Kidney Journal

Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial

Clinical Kidney Journal

Previous publication

Horner’s syndrome after chest drain insertion due to pneumothorax

Clinical Kidney Journal

Next publication

Authors

Arthur Orieux
Sébastien Rubin
Renaud Prevel
Antoine Garric
Didier Gruson
Alexandre Boyer